Alzheimer's Psychosis (ACP-204) Study
About This Study
We are conducting a research program to test a new medication called ACP-204 for adults with Alzheimer’s disease psychosis (hallucinations and delusions). The goal is to learn how safe the medication is, what dose works best, and whether it helps reduce symptoms.
The program is made up of three separate studies:
Study 1 (Phase 2): Tests two different doses of ACP-204 (30 mg and 60 mg) compared to placebo to see which works best.
Study 2A and Study 2B (Phase 3): Larger studies designed to confirm the results from Study 1, testing either one or both of the doses against placebo.
Each study will run on its own and will include:
A screening period (up to 7 weeks) to confirm eligibility.
A treatment period (6 weeks) where participants receive either ACP-204 or placebo without knowing which one.
A safety follow-up (about 30 days) for participants not continuing into a long-term extension study.
A final follow-up if a participant leaves the study early.
By joining, participants will receive study-related care at no cost while helping researchers explore a potential new treatment for Alzheimer’s disease psychosis.
Study Eligibility
Who Can Participate?
Age
Adults 50+
Gender
All genders welcome
Condition
Diagnosed with Alzheimer’s disease and experiencing hallucinations or delusions
Location
Daytona Beach, FL
Enrolling Now
Apply for the Study
Fill out the form below to see if you qualify for our Alzheimer’s Psychosis (ACP-204) study in Daytona Beach. Participation is completely voluntary, and all study-related care will be provided at no cost to you.
Why Join?
- Access to new treatments before they are widely available
- No cost to participate — insurance is not required
- Compensation for your time and travel
- Personalized medical care from experienced physicians
Study Sponsor
Acadia Pharmaceuticals
Advancing breakthroughs in CNS disorders
Acadia Pharmaceuticals develops therapies for central nervous system disorders, including Parkinson's disease psychosis, Rett syndrome, and Alzheimer's psychosis. Acadia is the sponsor of the ACP-204 clinical program in development at Arrow.
Why Participate in a Clinical Trial?
Participating in a clinical trial at Arrow Clinical Trials in Daytona Beach is an opportunity to take charge of your health while helping advance medical science — all while under the care of experienced local physicians.
- Access to new treatments before they are widely available
- No cost to participate — insurance is not required
- Compensation for your time and travel
- Personalized medical care from experienced physicians
Daytona Neurology Clinical Trials
Clinical Trial FAQs
What does psychosis mean in Alzheimer’s disease?
Psychosis includes symptoms like seeing or hearing things that aren’t there (hallucinations) or having false, often distressing beliefs (delusions). These symptoms can be very difficult for both patients and caregivers.
What types of clinical trials does Arrow Clinical Trials offer in Daytona Beach?
We currently conduct research studies in Hypertension, Orthopedics, Cardiology, and Neurology. Our trials include treatments for high blood pressure, joint pain, heart health, stroke recovery, migraines, and other conditions affecting the brain and nervous system.
What are the benefits of joining this study?
While we cannot guarantee that participants will see improvements, they will receive study-related medical care at no cost and help researchers explore new treatment options that may benefit people with Alzheimer’s disease in the future.
Do I need health insurance to participate?
No. All studies at Arrow Clinical Trials are provided at no cost to participants, and insurance is not required. Any procedures, tests, or study-related care will be covered by the trial sponsor.
Will I be compensated for joining a study?
Yes. Participants may receive compensation for their time and travel. The exact amount depends on the study and the number of visits required.
How do I know if I’m eligible for a trial in Daytona Beach?
Each study has specific requirements, such as age range, medical history, and current health status. Our research team will review your information and conduct a screening process to determine if you qualify.